Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released May 12, 2022, after the close
10-Q filed May 12, 2022, 42 days after period end · 0000950170-22-009747
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $3.22M | $828.00K | $309.00K | $158.00K |
| Net Income | -$4.49M | $2.06M | $2.53M | -$12.61M |
| EPS Diluted |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$8.09 |
| $0.11 |
| $0.29 |
| -$2.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.